GENE ONLINE|News &
Opinion
Blog

Gene Therapy
Trials & Approvals Gene TherapyRare Disease
Orchard Therapeutics’ Gene Therapy for Rare Neurological Disorder Wins FDA Approval
2024-03-20
R&D MRIGene Therapy
Groundbreaking Real-Time MRI Enhances Nervous System Gene Therapy
2024-01-30
Special biotech
GeneOnline’s Pick: Top 10 Global Biotech News Stories in 2023
2023-12-27
Asia-Pacific acquisition
Ajinomoto to Acquire Forge Biologics for $620 Million to Boost Gene Therapy Capabilities
2023-11-14
Editors' Picks TuberculosisEarly Cancer Detection
GeneOnline’s Weekly News Highlights: June 26-30
2023-07-03
Trials & Approvals Gene Therapymuscular dystrophy
Promising Clinical Data Supports Clinical Initiation of Epic Bio’s FSHD Therapy
2023-06-27
Special Cell and Gene Therapy
Revolutionizing Eye Disease Treatment with iPSC Therapy
2023-03-07
Special Cell and Gene Therapy
Global Head of Research of Kite Pharma Unveiled the Key Elements to Success in Adoptive Cell Therapy
2023-03-07
Trials & Approvals Gene Therapy
CSL’s Hemgenix Wins First Gene Therapy Approval For Hemophilia In Europe
2023-02-21
Trials & Approvals Gene Therapy
Immusoft’s B Cell Gene Therapy Gets FDA Nod to Enter Clinical Trials
2023-02-13
Ranking & Reports Gene Therapy
Patent Landscape Analysis of Gene Therapy
2023-02-08
Regulatory Gene Therapy
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Go Prime Gene Therapy
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Trials & Approvals Gene Therapy
Hemgenix Marks Most Expensive Treatment Ever and First Gene Therapy for Hemophilia B
2022-11-22
Asia-Pacific Astellas Pharma
Astellas Invests $50 Million In Taysha, Licenses Two CNS Gene Therapies
2022-10-25
1 2 3 … 9
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top